|
⚲
|
| Keyboard |
| Curis Inc | |
|---|---|
| Ticker | CRIS |
| CIK # | 0001108205 |
| CUSIP | 231269101 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 4 Maguire Road, Lexington, MA 02421 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Curis Inc | 2012-05-04 | 1.0 M | Exemption: 506 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001108205] | 10-K | |
| [0001108205] | 10-Q | |
| [0001108205] | 3 | |
| [0001108205] | 4 | |
| [0001108205] | 5 | |
| [0001108205] | 8-K | |
| [0001108205] | D | |
| [0001108205] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Duvall Diantha
Common Stock
|
2026-03-20 | Conversion | 66,666 | ||
|
Hamdy Ahmed MD
Series B Convertible Preferred Stock · derivative
|
2026-03-20 | Conversion | 50 | ||
|
Rubin Marc
Common Stock
|
2026-03-20 | Conversion | 26,667 | ||
|
Zung Jonathan B
Series B Convertible Preferred Stock · derivative
|
2026-03-20 | Conversion | 50 | ||
|
Dentzer James E
Series B Convertible Preferred Stock · derivative
|
2026-03-20 | Conversion | 100 | ||
|
Zung Jonathan B
Common Stock
|
2026-03-20 | Conversion | 66,667 | ||
|
Duvall Diantha
Series B Convertible Preferred Stock · derivative
|
2026-03-20 | Conversion | 50 | ||
|
Rubin Marc
Series B Convertible Preferred Stock · derivative
|
2026-03-20 | Conversion | 20 | ||
|
Dentzer James E
Common Stock
|
2026-03-20 | Conversion | 133,333 | ||
|
Hamdy Ahmed MD
Common Stock
|
2026-03-20 | Conversion | 66,667 | ||
|
Rubin Marc
Series A Warrant (right to buy) · derivative
|
2026-03-17 | Grant | 26,667 | ||
|
Dentzer James E
Series C Warrant (right to buy) · derivative
|
2026-03-17 | Grant | 133,333 | ||
|
Zung Jonathan B
Series C Warrant (right to buy) · derivative
|
2026-03-17 | Grant | 66,667 | ||
|
Rubin Marc
Series B Warrant (right to buy) · derivative
|
2026-03-17 | Grant | 26,667 | ||
|
Dentzer James E
Series B Warrant (right to buy) · derivative
|
2026-03-17 | Grant | 133,333 | ||
|
Zung Jonathan B
Series B Warrant (right to buy) · derivative
|
2026-03-17 | Grant | 66,667 | ||
|
Rubin Marc
Series C Warrant (right to buy) · derivative
|
2026-03-17 | Grant | 26,667 | ||
|
Duvall Diantha
Series B Convertible Preferred Stock · derivative
|
2026-03-17 | Grant | 50 | ||
|
Duvall Diantha
Series C Warrant (right to buy) · derivative
|
2026-03-17 | Grant | 66,666 | ||
|
Duvall Diantha
Series B Warrant (right to buy) · derivative
|
2026-03-17 | Grant | 66,666 | ||
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 42 | 15,766,510 |
| 2025-12-31 | 41 | 4,330,891 |
| 2025-09-30 | 41 | 4,613,046 |
| 2025-06-30 | 43 | 4,290,970 |
| 2025-03-31 | 41 | 4,668,971 |
| 2024-12-31 | 41 | 3,214,147 |
| 2024-09-30 | 33 | 2,017,493 |
| 2024-06-30 | 35 | 2,311,596 |
| 2024-03-31 | 37 | 2,090,281 |
| 2023-12-31 | 40 | 2,532,126 |
| 2023-09-30 | 39 | 2,343,206 |
| 2023-06-30 | 62 | 30,173,140 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Franklin Street Advisors Inc /NC | [2026-06-30] | DFND | 20,000 | 20,000 | Prev | Page 1 | Next |